Skip to main content
OpenTrials

Clinical trial condition

Advanced Solid Tumors

Explore clinical trials studying Advanced Solid Tumors. Study availability and eligibility vary by location and protocol.

609 public trials 183 recruiting studies
Refine in advanced search Browse all conditions

Advanced Solid Tumors trial results

Recruiting

A Rollover Study Evaluating Sotorasib With or Without Panitumumab in Participants With KRAS p.G12C Mutation

NCT07172919

Conditions
Advanced Solid Tumors
Locations
  • Florida Cancer Specialists - Fort Myers Fort Myers, Florida, United States
  • University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • Scientia Clinical Research Ltd Randwick, New South Wales, Australia
  • Centre Leon Berard Lyon, France
View Trial Details
Recruiting

A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors

NCT06004245

Conditions
Advanced Solid Tumors, Colonic Diseases, Colorectal Cancer, +14 more
Locations
  • City of Hope Cancer Center Duarte, California, United States
  • City of Hope at Irvine Lennar Irvine, California, United States
  • START Los Angeles Los Angeles, California, United States
  • Emory University School of Medicine Atlanta, Georgia, United States
View all 38 locations
View Trial Details
Recruiting

Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors

NCT07360314

Conditions
Adnexal Diseases, Advanced Solid Tumors, Breast Diseases, +29 more
Locations
  • Yale University - Yale University School of Medicine New Haven, Connecticut, United States
  • Carolina BioOncology Institute, LLC - Cancer Therapy and Research Center Huntersville, North Carolina, United States
  • NEXT Houston Galveston, Texas, United States
  • NEXT Oncology - PARENT San Antonio, Texas, United States
View Trial Details
Recruiting

Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors

NCT07397338

Conditions
Advanced Solid Tumors, Bronchial Neoplasms, CRC, +22 more
Locations
  • Eastern Connecticut Hematology and Oncology Associates Norwich, Connecticut, United States
  • Tennessee Oncology Nashville, Tennessee, United States
  • MD Anderson Cancer Center Houston, Texas, United States
  • NEXT Dallas Irving, Texas, United States
View Trial Details
Recruiting

Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors

NCT05533697

Conditions
Advanced Solid Tumors, Disease Attributes, Neoplasm Metastasis, +5 more
Locations
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • George Washington University Washington D.C., District of Columbia, United States
View all 39 locations
View Trial Details
Recruiting

Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors

NCT07349537

Conditions
Advanced Solid Tumors, Bronchial Neoplasms, CRC, +30 more
Locations
  • Yale Cancer Center New Haven, Connecticut, United States
  • Johns Hopkins Baltimore, Maryland, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • START Midwest Grand Rapids, Michigan, United States
View Trial Details
Recruiting

A Study to Investigate the Pharmacokinetics and Safety of Subcutaneous Rilvegostomig in Adult Participants With Advanced Solid Tumors Previously Treated With Standard of Care Therapy

NCT07161414

Conditions
Advanced Solid Tumors, Parkinson Disease 4, Autosomal Dominant Lewy Body
Locations
  • Research Site Huntersville, North Carolina, United States
  • Research Site San Antonio, Texas, United States
  • Research Site Fairfax, Virginia, United States
  • Research Site Seoul, South Korea
View Trial Details

Related conditions